146 related articles for article (PubMed ID: 30089900)
1. Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients.
Kerep AZ; Broome J; Pirsl F; Curtis LM; Steinberg SM; Mitchell SA; Cowen EW; Pichard DC; Joe GO; Comis LE; Mays JW; Datiles MB; Stratton P; Zolton J; Berger A; Hendricks J; Kenyon M; Baruffaldi J; Titarenko I; Pulanic D; Baird K; Fowler DH; Gress RE; Pavletic SZ
Bone Marrow Transplant; 2019 Jan; 54(1):76-84. PubMed ID: 30089900
[TBL] [Abstract][Full Text] [Related]
2. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.
Baird K; Steinberg SM; Grkovic L; Pulanic D; Cowen EW; Mitchell SA; Williams KM; Datiles MB; Bishop R; Bassim CW; Mays JW; Edwards D; Cole K; Avila DN; Taylor T; Urban A; Joe GO; Comis LE; Berger A; Stratton P; Zhang D; Shelhamer JH; Gea-Banacloche JC; Sportes C; Fowler DH; Gress RE; Pavletic SZ
Biol Blood Marrow Transplant; 2013 Apr; 19(4):632-9. PubMed ID: 23340040
[TBL] [Abstract][Full Text] [Related]
3. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
4. Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD.
Kim DY; Lee JH; Lee JH; Kim SH; Lim SN; Kim SD; Choi Y; Lee YS; Kang YA; Kang SI; Seol M; Ryu SG; Lee KH
Bone Marrow Transplant; 2010 Jul; 45(7):1174-80. PubMed ID: 19915630
[TBL] [Abstract][Full Text] [Related]
5. Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity.
Aki SZ; Inamoto Y; Carpenter PA; Storer BE; Sandmaier BM; Lee SJ; Martin PJ; Flowers ME
Bone Marrow Transplant; 2016 Oct; 51(10):1350-1353. PubMed ID: 27214071
[TBL] [Abstract][Full Text] [Related]
6. Chronic graft-versus-host disease features in double unit cord blood transplantation according to National Institutes of Health 2005 cGVHD Consensus criteria.
Hayashi H; Ruggeri A; Volt F; Cornelissen JJ; Socié G; Sengeloev H; Michallet M; Karakasis D; Petersen E; Cahn JY; Veelken H; Mercier M; Rohrlich PS; Rafii H; Kenzey C; Xavier E; Duarte RF; Basak GW; Rocha V; Gluckman E;
Bone Marrow Transplant; 2018 Apr; 53(4):417-421. PubMed ID: 29330402
[No Abstract] [Full Text] [Related]
7. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria.
Sato T; Ichinohe T; Kanda J; Yamashita K; Kondo T; Ishikawa T; Uchiyama T; Takaori-Kondo A
Int J Hematol; 2011 Apr; 93(4):532-541. PubMed ID: 21465116
[TBL] [Abstract][Full Text] [Related]
8. Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease Patients.
Curtis LM; Pirsl F; Steinberg SM; Mitchell SA; Baird K; Cowen EW; Mays J; Buxbaum NP; Pichard DC; Im A; Avila D; Taylor T; Fowler DH; Gress RE; Pavletic SZ
Biol Blood Marrow Transplant; 2017 Nov; 23(11):1980-1988. PubMed ID: 28797782
[TBL] [Abstract][Full Text] [Related]
9. Evolving concepts in prognostic scoring of chronic GvHD.
Lazaryan A; Arora M
Bone Marrow Transplant; 2017 Oct; 52(10):1361-1366. PubMed ID: 28346419
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria.
Pengpis N; Prueksrisakul T; Chanswangphuwana C
Med Oral Patol Oral Cir Bucal; 2023 Mar; 28(2):e167-e173. PubMed ID: 36173715
[TBL] [Abstract][Full Text] [Related]
11. Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review.
Milosevic E; Babic A; Iovino L; Markovic M; Grce M; Greinix H
Front Immunol; 2022; 13():1033263. PubMed ID: 36389657
[TBL] [Abstract][Full Text] [Related]
12. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.
Arai S; Jagasia M; Storer B; Chai X; Pidala J; Cutler C; Arora M; Weisdorf DJ; Flowers ME; Martin PJ; Palmer J; Jacobsohn D; Pavletic SZ; Vogelsang GB; Lee SJ
Blood; 2011 Oct; 118(15):4242-9. PubMed ID: 21791424
[TBL] [Abstract][Full Text] [Related]
13. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD).
Elad S; Zeevi I; Or R; Resnick IB; Dray L; Shapira MY
Biol Blood Marrow Transplant; 2010 Jan; 16(1):62-9. PubMed ID: 19733252
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.
Greinix HT; Loddenkemper C; Pavletic SZ; Holler E; Socié G; Lawitschka A; Halter J; Wolff D
Biol Blood Marrow Transplant; 2011 Feb; 17(2):167-75. PubMed ID: 20691801
[TBL] [Abstract][Full Text] [Related]
15. National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen.
Saillard C; Crocchiolo R; Furst S; El-Cheikh J; Castagna L; Signori A; Oudin C; Faucher C; Lemarie C; Chabannon C; Granata A; Blaise D
Leuk Lymphoma; 2014 May; 55(5):1106-12. PubMed ID: 23822538
[TBL] [Abstract][Full Text] [Related]
16. Oral chronic graft-versus-host disease scoring using the NIH consensus criteria.
Treister NS; Stevenson K; Kim H; Woo SB; Soiffer R; Cutler C
Biol Blood Marrow Transplant; 2010 Jan; 16(1):108-14. PubMed ID: 19772943
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.
Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
Leukemia; 2009 Jan; 23(1):78-84. PubMed ID: 18830253
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
[TBL] [Abstract][Full Text] [Related]
19. Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters.
Vukić T; Robinson Smith S; Ljubas Kelečić D; Desnica L; Prenc E; Pulanić D; Vrhovac R; Nemet D; Pavletic SZ
Croat Med J; 2016 Jun; 57(3):266-75. PubMed ID: 27374828
[TBL] [Abstract][Full Text] [Related]
20. Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
Cardones AR; Sullivan KM; Green C; Chao NJ; Rowe-Nichols K; Bañez LL; Burton CS; Horwitz ME; Long GD; Rao CL; Sarantopoulos S; Sidhu-Malik N; Sung AD; Hall RP
JAMA Dermatol; 2019 Jul; 155(7):833-837. PubMed ID: 30994873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
